EAM Investors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$641K	Buy	+99,960	New	+$641K	0.1%	197
2023 Q1	–	Sell	-65,272	Closed	-$2.41M	–	252
2022 Q4	$2.41M	Buy	+65,272	New	+$2.41M	0.5%	64